The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapie...
The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapies
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
Relapsed refractory multiple myeloma (RRMM) is a disease that is nonresponsive or progressive on therapy, and although patients can achieve remission, relapse is common. As more treatment options become available for multiple myeloma (MM), it is important to understand patients' experiences of current and emerging therapies.
Aims
Alternative Titles
Full title
The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapies
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c9d79d89b0824151be0bc16f3e3cf2d1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c9d79d89b0824151be0bc16f3e3cf2d1
Other Identifiers
ISSN
2573-8348
E-ISSN
2573-8348
DOI
10.1002/cnr2.1603
